top of page
Abstract Red Transitions

Cell Line Development Service

  • 20250618_laboratory-31.jpg
  • 20250618_laboratory-5.jpeg
  • 20250618_laboratory-40.jpg
  • 20250618_laboratory-23_edited.jpg
  • 20250618_laboratory-9_edited.jpg
  • 20250618_laboratory-50.jpg
  • 分注機1_edited.jpg

CHITOSE developed the CHO-MK expression platform to deliver a modern, high-performance system for the industry.

 

Our proprietary technology ensures rapid, high-yield development of biologics, accelerating your manufacturing.

>10 g/L

Titer

Our Track Record at a Glance

5 Days

Culture Time

70+

Completed projects

Derived from primary Chinese Hamster Ovary (CHO) tissues isolated de novo in 2016, CHO-MK host cells possess unique biological characteristics.

They exhibit metabolic efficiency and growth profiles that significantly surpass current industry standards.

High Performance CHO Cells 

  • Applicable for biopharmaceutical production
  • Adapted to complete serum-free suspension culture
  • Passed viral safety tests
  • Completed Host Cell Bank testing package (CoA)

Our Journey

2002

2016

2018

Chitose Laboratory

established

CHO-MK Cell Line

established for medical purposes

Cell Line Development (CLD)

business started

001.png

Workflow

002.png

Transfection

Stable Pool Enrichment

Single-Cell Cloning 

Pre-Master Cell Bank (PCB)

Technology Transfer

003.png
004.png
005.png
フラスコ3.jpg

What We Provide

High-Productivity Stable Cell Lines
Comprehensive Experimental Report
Pre-Master Cell Bank (PCB)
Common
Technical Documents (CTD)
bottom of page